Jeil Pharma Holdings Inc (KRX:002620)

Jeil Pharma Holdings Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	140,923	120,046	180,683	236,407	245,618	325,444
Market Cap Growth	-22.60%	-33.56%	-23.57%	-3.75%	-24.53%	24.71%
Enterprise Value	365,376	328,142	429,021	424,544	404,795	543,483
Last Close Price	9180.00	7820.00	11694.36	15235.70	15769.33	20811.81
PE Ratio	-	-	-	-	-	28.47
PS Ratio	0.18	0.15	0.23	0.30	0.32	0.43
PB Ratio	0.32	0.27	0.45	0.56	0.49	0.65
P/TBV Ratio	0.47	0.40	0.67	0.91	0.96	1.39
P/FCF Ratio	-	593.17	-	-	-	-
P/OCF Ratio	-	26.43	-	-	18.33	-
EV/Sales Ratio	0.47	0.42	0.53	0.54	0.53	0.71
EV/EBITDA Ratio	37.80	112.46	12.82	126.46	48721.60	17.73
EV/EBIT Ratio	-	-	20.51	-	-	24.70
EV/FCF Ratio	-31.11	1621.42	-	-	-	-
Debt / Equity Ratio	0.36	0.36	0.53	0.39	0.23	0.30
Debt / EBITDA Ratio	16.64	53.19	6.40	48.44	13850.20	4.89
Debt / FCF Ratio	-	766.93	-	-	-	-
Asset Turnover	0.88	0.88	0.92	0.90	0.86	0.88
Inventory Turnover	4.46	4.61	4.94	5.38	4.88	5.17
Quick Ratio	0.77	0.73	0.61	0.65	0.71	0.63
Current Ratio	1.12	1.08	0.93	0.98	1.13	1.02
Return on Equity (ROE)	-13.99%	-15.82%	-3.22%	-18.07%	-2.57%	3.05%
Return on Assets (ROA)	-0.31%	-0.79%	1.50%	-0.54%	-0.63%	1.59%
Return on Capital (ROIC)	-0.46%	-1.16%	2.18%	-0.79%	-0.89%	2.19%
Return on Capital Employed (ROCE)	-	-	4.50%	-	-	3.90%
Earnings Yield	-34.70%	-42.62%	-8.99%	-31.54%	-1.42%	3.51%
FCF Yield	-8.33%	0.17%	-5.89%	-13.84%	-4.19%	-10.29%
Dividend Yield	0.54%	0.64%	0.43%	0.33%	0.41%	0.34%
Payout Ratio	-	-	-	-	-	13.88%
Buyback Yield / Dilution	-1.79%	-	-	-	-	-
Total Shareholder Return	-1.24%	0.64%	0.43%	0.33%	0.41%	0.34%

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.